Radio NZ News 23 September 2020
Our additional comment: “Research by the New Zealand Medical Journal and published by NZ Doctor in June, showed that 79 percent of GPs in New Zealand had concerns prescribing it. Medical director of the Royal New Zealand College of General Practitioners, Dr Bryan Betty said there was still not enough evidence of its benefits.”
Cannabis became legal medicine in New Zealand in April.
One of New Zealand’s newest medical cannabis companies, Tauranga based Eqalis, said a medical diagnosis was needed in order to get the full effect of medical cannabis, for the condition being treated.
Chief medical officer Elizabeth Plant said medical cannabis was complex and in order to work properly, specific ratios of compounds were needed in the active ingredients.
“You have to make sure the dose is safe and effective and it’s more about low THC and high CBD.”
Tetrahydrocannabinol (THC) and cannabidiol (CBD) were the two primary cannabinoids that occur naturally in the Cannabis sativa plant.
CBD was non-psychoactive, meaning it would not get the user high, and therefore appeared more frequently than THC in dietary and natural supplements.
Plant said prescribing for medical use was a delicate balance.
Research by the New Zealand Medical Journal and published by NZ Doctor in June, showed that 79 percent of GPs in New Zealand had concerns prescribing it.
READ MORE: https://www.rnz.co.nz/news/national/426757/medicinal-cannabis-still-not-favoured-by-doctors